aod9604 dosage AOD-9604 Guide: Complete Protocol for Safe Administration AOD-9604 + CJC-1295 + Ipamorelin

Week 12+: Maximum benefits Three months is the sweet spot for AOD 9604

Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials

Higher doses may increase gastrointestinal side effects without improving outcomes

- Liver enzymes if any preexisting liver concern, given the monkey toxicology signal